Some 22% of American women and 14% of men have taken GLP-1s for weight loss or for chronic conditions such as diabetes. In charts we show the social and economic effects https://t.co/7Pvg34x5gD ...

Popular weight loss drugs have remained out of reach for most older Americans in Medicare for years. That's because GLP-1s can cost hundreds of dollars per month, but that changes this week. Starting Wednesday, millions of eligible Medicare patients can access GLP-1 obesity drugs from [music] Novo Nordisk and Eli Lilly for a copay of just $50 per month.It's a major shift for a federal program that has traditionally barred coverage of medications prescribed solely for obesity. So, what happened. Well, there' ...